08 Feb 2025
The value of WATCHMAN therapy - Who should we treat?
Sponsored by Boston Scientific
Anchorperson:
K. Hayashida
Summary
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI patients. Gain insights that will help you optimize patient selection and deliver the best possible outcomes for your patients.
Learning Objectives
- To understand the latest evidence and the value of WATCHMAN therapy
- To imagine the patient who would benefit from WATCHMAN therapy